Insider Selling: Phreesia (NYSE:PHR) Insider Sells 8,332 Shares of Stock

Key Points

• David Linetsky, a Phreesia insider, sold 8,332 shares on April 10 at an average price of $8.07 under a Rule 10b5-1 plan to cover tax withholding from vested awards, trimming his stake by 3.59% to 224,056 shares (worth about $1.81M).
• Phreesia shares climbed to $8.55 after the sale; the company reported Q1 EPS of $0.02 (missing estimates by $0.05) with revenue up 15.9% to $127.07M, and analysts maintain a "Moderate Buy" consensus with an average target price of $20.82.

Phreesia, Inc. (NYSE:PHR - Get Free Report) insider David Linetsky sold 8,332 shares of the business's stock in a transaction dated Friday, April 10th. The shares were sold at an average price of $8.07, for a total transaction of $67,239.24. Following the transaction, the insider owned 224,056 shares in the company, valued at $1,808,131.92. This represents a 3.59% decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available through this link. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. The sale was made to cover tax withholding obligations related to the vesting of equity awards.

David Linetsky also recently made the following trade(s):

• On Wednesday, March 18th, David Linetsky sold 107 shares of Phreesia stock. The shares were sold at an average price of $11.06, for a total transaction of $1,183.42.
• On Friday, January 16th, David Linetsky sold 6,038 shares of Phreesia stock. The shares were sold at an average price of $16.36, for a total transaction of $98,781.68.
• On Thursday, January 15th, David Linetsky sold 1,743 shares of Phreesia stock. The shares were sold at an average price of $16.38, for a total transaction of $28,550.34.

Phreesia Trading Up 6.1%

Shares of NYSE PHR traded up $0.49 during midday trading on Monday, hitting $8.55. 2,201,789 shares of the company traded hands, compared to its average volume of 2,867,051. Phreesia, Inc. has a 12-month low of $7.77 and a 12-month high of $32.76. The company has a debt-to-equity ratio of 0.41, a quick ratio of 1.53 and a current ratio of 1.53. The stock has a 50-day moving average price of $11.23 and a 200 day moving average price of $16.60. The firm has a market cap of $519.74 million, a P/E ratio of 285.13 and a beta of 0.86.

Phreesia (NYSE:PHR - Get Free Report) last announced its quarterly earnings results on Monday, March 30th. The company reported $0.02 earnings per share (EPS) for the quarter, missing the consensus estimate of $0.07 by ($0.05). Phreesia had a net margin of 0.48% and a return on equity of 3.23%. The company had revenue of $127.07 million for the quarter, compared to analysts' expectations of $126.75 million. During the same quarter in the prior year, the firm earned ($0.11) EPS. Phreesia's quarterly revenue was up 15.9% compared to the same quarter last year. As a group, analysts expect that Phreesia, Inc. will post -1.1 earnings per share for the current year.

Institutional Investors Weigh In On Phreesia

A number of hedge funds and other institutional investors have recently bought and sold shares of the business. Vanguard Group Inc. increased its position in shares of Phreesia by 8.3% during the third quarter. Vanguard Group Inc. now owns 5,704,786 shares of the company's stock valued at $134,177,000 after acquiring an additional 437,462 shares in the last quarter. New York State Common Retirement Fund raised its holdings in Phreesia by 727.1% in the 3rd quarter. New York State Common Retirement Fund now owns 136,856 shares of the company's stock worth $3,219,000 after acquiring an additional 120,309 shares during the last quarter. Squarepoint Ops LLC raised its holdings in Phreesia by 243.6% in the 2nd quarter. Squarepoint Ops LLC now owns 100,922 shares of the company's stock worth $2,872,000 after acquiring an additional 71,553 shares during the last quarter. Greenhouse Funds LLLP raised its holdings in Phreesia by 16.8% in the 3rd quarter. Greenhouse Funds LLLP now owns 3,882,527 shares of the company's stock worth $91,317,000 after acquiring an additional 557,265 shares during the last quarter. Finally, Bessemer Group Inc. raised its holdings in Phreesia by 1,065.9% in the 3rd quarter. Bessemer Group Inc. now owns 554,513 shares of the company's stock worth $13,043,000 after acquiring an additional 506,954 shares during the last quarter. Hedge funds and other institutional investors own 92.10% of the company's stock.

Wall Street Analyst Weigh In

Several equities analysts recently issued reports on PHR shares. Stephens reduced their price target on shares of Phreesia from $32.00 to $20.00 and set an "overweight" rating on the stock in a research report on Tuesday, March 31st. Barclays cut their price objective on shares of Phreesia from $26.00 to $24.00 and set an "overweight" rating on the stock in a report on Tuesday, December 16th. BMO Capital Markets cut their price objective on shares of Phreesia from $32.00 to $14.00 and set an "outperform" rating on the stock in a report on Tuesday, March 31st. Wall Street Zen cut shares of Phreesia from a "buy" rating to a "hold" rating in a report on Saturday, April 4th. Finally, Needham & Company LLC cut their price objective on shares of Phreesia from $35.00 to $14.00 and set a "buy" rating on the stock in a report on Tuesday, March 31st. Twelve research analysts have rated the stock with a Buy rating, six have issued a Hold rating and one has issued a Sell rating to the stock. According to data from MarketBeat.com, Phreesia presently has an average rating of "Moderate Buy" and an average target price of $20.82.

Phreesia Company Profile

Phreesia, Inc NYSE: PHR is a provider of patient intake management solutions designed to streamline front-office workflows for healthcare organizations. The company's cloud-based platform digitizes patient registration, appointment scheduling, insurance verification, consent documentation and payment collection through touchscreen kiosks, tablets and mobile devices. By replacing paper forms and manual processes, Phreesia enhances data accuracy, reduces administrative burden and improves the patient experience.

Founded in 2000 by Chaim Indig and headquartered in Burlington, Massachusetts, Phreesia offers a modular software suite that integrates with electronic medical record (EMR) and practice management systems.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.